Hexarad raised €13M in a funding round in Aug 2024. The company is based in London, UK. Investors in the round: Existing Shareholders, Foresight Group, MedTech Innovation Partners - MTIP. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €13M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
